Correlation Between Biomarin Pharmaceutical and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and Mereo BioPharma Group, you can compare the effects of market volatilities on Biomarin Pharmaceutical and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and Mereo BioPharma.
Diversification Opportunities for Biomarin Pharmaceutical and Mereo BioPharma
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Biomarin and Mereo is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Biomarin Pharmaceutical and Mereo BioPharma
Given the investment horizon of 90 days Biomarin Pharmaceutical is expected to generate 0.44 times more return on investment than Mereo BioPharma. However, Biomarin Pharmaceutical is 2.29 times less risky than Mereo BioPharma. It trades about -0.28 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.17 per unit of risk. If you would invest 6,998 in Biomarin Pharmaceutical on August 24, 2024 and sell it today you would lose (653.00) from holding Biomarin Pharmaceutical or give up 9.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biomarin Pharmaceutical vs. Mereo BioPharma Group
Performance |
| Timeline |
| Biomarin Pharmaceutical |
| Mereo BioPharma Group |
Biomarin Pharmaceutical and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biomarin Pharmaceutical and Mereo BioPharma
The main advantage of trading using opposite Biomarin Pharmaceutical and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |